Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96

NCT02133079 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cancer
Pancreatic Adenocarcinoma

Interventions

BIOLOGICAL: autologous gp96 vaccination

Sponsor

Cure&Sure Biotech Co., LTD

Collaborators

[object Object]